Us Bioresorbable Stent (BRS) Device Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Bioresorbable Stent (BRS) Device Market was valued at USD 0.95 Billion in 2022 and is projected to reach USD 2.67 Billion by 2030, growing at a CAGR of 15.20% from 2024 to 2030.
The US bioresorbable stent (BRS) device market is experiencing significant growth, driven by technological advancements and increased demand for minimally invasive cardiovascular procedures. Bioresorbable stents are a revolutionary development in the medical field, offering a temporary scaffold for blood vessels that gradually dissolves over time, eliminating the need for a permanent implant. This feature provides patients with long-term benefits, as it reduces complications associated with traditional metal stents, such as thrombosis or restenosis.
The growing prevalence of cardiovascular diseases, particularly in the US, is fueling the demand for innovative treatments like bioresorbable stents. According to market research, the adoption of these devices has been accelerating due to their potential for improved patient outcomes, fewer side effects, and enhanced biocompatibility. BRS devices are proving to be a promising alternative to traditional stenting methods, as they offer the ability to restore vascular function without the need for permanent foreign materials.
In addition to their clinical benefits, bioresorbable stents are also gaining traction due to the increasing focus on sustainable and patient-centered healthcare solutions. The technology behind BRS has evolved significantly, with companies now focusing on the development of stents made from biodegradable polymers or metals. These stents are designed to provide structural support during the healing process and then gradually break down into harmless byproducts, offering a significant advancement in cardiovascular treatment.
As the US bioresorbable stent device market continues to expand, competition among manufacturers is intensifying. Companies are investing in research and development to improve the efficacy, safety, and durability of BRS devices. Market players are also looking to reduce costs to make these advanced devices more accessible to a broader patient demographic. Meanwhile, the regulatory environment and clinical trial results are playing a crucial role in the market's growth trajectory, with approval from major regulatory bodies such as the FDA being a key factor for market success.
In this rapidly evolving landscape, the integration of cutting-edge technology is also paving the way for new innovations. Similar to advancements seen in other medical devices, such as the 100 Gigabit Fiber Optic Transceiver Market, bioresorbable stents are benefitting from continuous improvements that ensure higher performance and better patient outcomes.
Get an In-Depth Research Analysis of the Global Bioresorbable Stent (BRS) Device Market Size And Forecast [2025-2032]
Â
Lepu Medical
Biotronik
Abbott
REVA
MeKo
Boston Scientific Corporation
Arterius Limited
Kyoto Medical Planning Co. Ltd
Terumo Corporation
Elixir Medical Corporation
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Bioresorbable Stent (BRS) Device Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Bioresorbable Stent (BRS) Device Market
Bioresorbable Polymer Stents
Bioresorbable Metal Stents
Fully Bioresorbable Stents
Partially Bioresorbable Stents
Coronary Artery Disease
Peripheral Artery Disease
Neurovascular Intervention
Structural Heart Diseases
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Research Facilities
Biodegradable Polymers
Metallic Biomaterials
Composite Materials
Natural Polymers
Direct Sales
Online Sales
Wholesale Distributors
Retail Pharmacies
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Bioresorbable Stent (BRS) Device Market Research Analysis
1. Introduction of the Global Bioresorbable Stent (BRS) Device Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Bioresorbable Stent (BRS) Device Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Bioresorbable Stent (BRS) Device Market, By Type
6. Global Bioresorbable Stent (BRS) Device Market, By Application
7. Global Bioresorbable Stent (BRS) Device Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Bioresorbable Stent (BRS) Device Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/